Stock Market Reviews

Read and share opinions on SHPH (Shuttle Pharmaceuticals Holdings, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in th

Latest News

• Shuttle Pharmaceuticals Acquires AI Health Platform
  Nov 21, 2025
• Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00
  Nov 3, 2025
• Shuttle Pharmaceuticals to Acquire AI Molecular Modeling and Predictive Analytics Platform
  Oct 21, 2025
• Shuttle Executes LOI with Molecule.ai
  Oct 10, 2025
• Shuttle to Enter $3.24 Billion AI Pharmaceutical Market
  Oct 9, 2025
• Shuttle Pharma Provides Second Quarter 2025 Corporate Update
  Aug 14, 2025
• Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market
  Jun 24, 2025
• Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market
  Jun 20, 2025
• Shuttle Pharmaceuticals says reverse stock split to become effective June 16
  Jun 13, 2025
• Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time
  Jun 12, 2025
• Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative
  Jun 12, 2025
• Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors
  Jun 4, 2025
• Shuttle Pharma Provides Corporate Update
  May 15, 2025
• Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial
  May 8, 2025
• Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
  Apr 21, 2025
• Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering
  Mar 13, 2025

SHPH News

• Shuttle Pharmaceuticals Acquires AI Health Platform
  Rockville, Maryland--(Newsfile Corp. - November 21, 2025) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle" or the "Company") today announced that it has closed the acquisition of the assets and liabilities of 1542770 B.C. Ltd. d/b/a Molecule.ai ("Molecule"), a Canadian artificial intelligence company specializing in molecular discovery and drug development technologies.Under the terms of the agreement, 1563868 B.C. Ltd., a wholly owned subsidiary of Shuttle, acquired...
  Nov 21, 2025
• Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00
  Gaithersburg, Maryland--(Newsfile Corp. - November 3, 2025) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle Pharma" or the "Company"), today announced that it entered into a securities purchase agreement with a single investor for aggregate gross proceeds of approximately $2.5 million (the "Offering"), before deducting fees to the placement agent and other offering expenses payable by the Company. The Company intends to use the net proceeds from the Offering for marketing,...
  Nov 3, 2025
• Shuttle Pharma and the Moment Science Learned to Think for Itself (NASDAQ:SHPH)
  ROCKVILLE, MD / ACCESS Newswire / October 22, 2025 / Every generation has its frontier. For the last century, medicine's remained molecular: genes, proteins, receptors, the invisible mechanics of life. Today, that frontier is shifting again. The next ...
  Oct 22, 2025
• Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI (NASDAQ:SHPH)
  ROCKVILLE, MD / ACCESS Newswire / October 22, 2025 / Artificial intelligence has reshaped nearly every industry, but drug discovery has always been its toughest proving ground. Molecules don't follow patterns; they twist, bind, and defy prediction, ...
  Oct 22, 2025
• Shuttle Pharma Turns Radiation Into a Smart Weapon With Definitive LOI for Molecule.ai (NASDAQ:SHPH)
  ROCKVILLE, MD / ACCESS Newswire / October 21, 2025 / Radiation therapy has always been the heavyweight of cancer treatment. It works, but it's a brute. It blasts cancer cells, hoping the good ones can withstand the damage. For decades, that was the ...
  Oct 21, 2025
• Shuttle Pharmaceuticals to Acquire AI Molecular Modeling and Predictive Analytics Platform
  Rockville, Maryland--(Newsfile Corp. - October 21, 2025) - Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) ("Shuttle" or the "Company") today announced that it has entered into a binding term sheet with 1542770 BC Ltd. ("Molecule"), a Canadian artificial intelligence company specializing in molecular discovery and drug development technologies.Under the terms of the agreement, Shuttle or one of its affiliates will acquire substantially all of Molecule's assets and liabilities for a total..
  Oct 21, 2025
• Shuttle Executes LOI with Molecule.ai
  GAITHERSBURG, Md., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company, today announced the execution of a non-binding letter of Intent with Molecule.ai. Molecule.ai, a pioneering artificial intelligence company founded by AI scientist and researcher Dr. ZT Zhang, PhD, today announced the execution of a letter of Intent to acquire Molecule.ai and its state-o
  Oct 10, 2025
• Shuttle to Enter $3.24 Billion AI Pharmaceutical Market
  GAITHERSBURG, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company, today announced the execution of a non-binding letter of Intent with Molecule.ai. Molecule.ai, a pioneering artificial intelligence company founded by AI scientist and researcher Dr. ZT Zhang, PhD, today announced the execution of a letter of Intent to acquire Molecule.ai and its state-o
  Oct 9, 2025
• Shuttle Pharma Provides Second Quarter 2025 Corporate Update
  GAITHERSBURG, Md., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today provided a corporate update. Recent Activities: Patient enrollment in the Company’s Phase 2 clinical trial of Ropidoxuridine for treatment of patients with glioblastoma reached 63% in the initial
  Aug 14, 2025
• Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market
  GAITHERSBURG, Md., June 24, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today announced that it closed its previously announced private placement pursuant to a securities purchase agreement with an accredited investor for aggregate gross proceeds of $4.25 million, before de
  Jun 24, 2025
• Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market
  GAITHERSBURG, Md., June 20, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today announced that it entered into a securities purchase agreement with an accredited investor for aggregate gross proceeds of $4.25 million, before deducting fees to the placement agent and other off
  Jun 20, 2025
• Shuttle Pharmaceuticals says reverse stock split to become effective June 16
  Shuttle Pharmaceuticals (SHPH) announced that the reverse stock split will become effective on June 16, at 12:01 a.m., Eastern Time. The company’s common stock will continue to trade on The Nasdaq Capital Market under the existing symbol “SHPH” and will begin trading on a split-adjusted basis when the market opens on June 16. At the effective time of the reverse stock split, every 25 shares of the company’s issued and outstanding common stock will be automatically reclassified and combined into
  Jun 13, 2025
• Shuttle Pharma Announces Reverse Stock Split will Become Effective on June 16, 2025, at 12:01 a.m., Eastern Time
  GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT) announces that the reverse stock split will become effective on June 16, 2025, at 12:01 a.m., Eastern Time. The Company’s common stock will continue to trade on The Nasdaq Capital Market (“Nasdaq”) under
  Jun 12, 2025
• Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative
  GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), announces that its Board of Directors have approved a proposed reverse stock split of its common stock at a ratio of 25-for-1. The proposed action remains subject to approval by Nasdaq and, if approved,
  Jun 12, 2025
• Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors
  GAITHERSBURG, Md., June 04, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today announced the appointment of George Scorsis as the Chairman of the Board of Directors. Mr. Scorsis has served as director of the Company since February 2025. Mr. Scorsis has over 25 years of exper
  Jun 4, 2025
• Shuttle Pharma Provides Corporate Update
  GAITHERSBURG, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today provided a corporate update. Shuttle Pharma’s recent highlights: Phase 2 clinical trial of Ropidoxuridine for treatment of patients with glioblastoma highlights include: Patient enrollment nears mi
  May 15, 2025
• Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial
  GAITHERSBURG, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), announced today that it has nearly achieved 50% enrollment in the initial randomized portion of its Phase 2 clinical trial of Ropidoxuridine for the treatment of patients with glioblastoma, with treatmen
  May 8, 2025
• Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
  Company to conduct 1x1 meetings on April 24, 2025GAITHERSBURG, Md., April 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025, at
  Apr 21, 2025
• Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer
  Filing provisional patent application with the USPTO entitled “PSMA-Targeted PARP Inhibitor conjugates for Precision Cancer Therapy” key to advancement of Diagnostic and Therapeutic programs Dr. Alan Kozikowski, internationally acclaimed pioneer in the discovery of a critical PSMA targeting ligand for clinical applications is co-inventor Theranostic molecule designed to preferentially target prostate cancer cells to the effects of radiation and chemotherapeutic agents GAITHERSBURG, Md., April 10
  Apr 10, 2025
• Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering
  GAITHERSBURG, Md., March 13, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), announced today the closing of its previously announced underwritten public offering of 19,166,667 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) at a public offering price
  Mar 13, 2025
• Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering
  GAITHERSBURG, Md., March 12, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), announced today the pricing of an underwritten public offering of 19,166,667 shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) at a public offering price of $0.30 per share (t
  Mar 12, 2025

SHPH Reviews

• BearHunter

  Dec 31, 2025

  $SHPH This one’s like that friend who always finds a way to turn any boring night into an adventure—keep an eye on it!

  Buy

• FinTechFrost

  Dec 31, 2025

  $SHPH With a name like that, you’d think they’re just here for a wild party—get ready for some unexpected side effects!

  Buy

• MarketMatrix

  Dec 30, 2025

  $SHPH Their pharmaceuticals are like magic potions! Just no dragons, please. We don't need that kind of drama!

  Buy

• ChartFang

  Dec 29, 2025

  $SHPH With a focus on pharmaceutical advancements, this firm is pushing boundaries in drug development, creating a buzz in the healthcare market.

  Buy

• QuantKnight

  Dec 29, 2025

  $SHPH With so much hype around innovative treatments, this one could either skyrocket or crash spectacularly. The pressure is palpable as investors weigh potential breakthroughs against the ever-present risks. What a rollercoaster!

  Buy

• ByteBull

  Dec 29, 2025

  $SHPH This stock has more potential than your summer plans for a road trip—exciting and slightly unpredictable!

  Sell

• BuyLowBro

  Dec 29, 2025

  $SHPH This one’s like a scientist in a lab coat trying to make sense of the market. We just hope it doesn’t blow anything up!

  Buy

• ChartPhantom

  Dec 29, 2025

  $SHPH This stock is like a plot twist in a movie—you never see it coming, but it could change everything!

  Buy

• TradeMatrix

  Dec 29, 2025

  $SHPH This pharmaceutical player is caught in a whirlwind of uncertainty—promising research and development efforts that could either catapult it to the forefront or disappear without a trace. The clock is ticking!

  Sell

• VolatilityViper

  Dec 28, 2025

  $SHPH Another biotech that probably won't cure anything.

  Sell

• RiskReaper

  Dec 28, 2025

  $SHPH This company is exploring new avenues in pharmaceuticals with a focus on enhancing patient outcomes. Its innovative projects and commitment to addressing critical health issues could lead to significant industry advancements.

  Buy

• MoonBagz

  Dec 28, 2025

  $SHPH Pharma moves smooth, playin' the health game hard!

  Buy

• StockStrider

  Dec 27, 2025

  $SHPH Engagement in the pharmaceutical sector with a focus on unique treatment options suggests potential for impactful breakthroughs and a bright future.

  Buy

• OptionCipher

  Dec 26, 2025

  $SHPH With all the buzz in pharmaceuticals lately, it's either going to skyrocket or plummet! Can you handle the rollercoaster? The stakes are higher than ever!

  Buy

• TradePulse

  Dec 26, 2025

  $SHPH Pharmaceutical developments can change overnight! Is this company on the brink of a breakthrough or just teetering on the edge of obscurity? The suspense is killing me!

  Buy

• BearMarketSurvivor

  Dec 25, 2025

  $SHPH Yo, this joint's got mad potential to blow up, keep an eye on it!

  Buy

• TradeGoblin

  Dec 25, 2025

  $SHPH Pharmaceutical hustle on the grind, but don’t get too cozy, ya know?

  Sell

• BullishShade

  Dec 25, 2025

  $SHPH With a focus on pioneering pharmaceutical solutions, this company is committed to addressing unmet medical needs. Their innovative research and development efforts may position them as a key player in the industry.

  Buy

• TheQuantEdge

  Dec 25, 2025

  $SHPH The rollercoaster of pharmaceutical stocks always leaves investors on edge. Is this the next miracle or just another heart-wrenching disappointment waiting to happen?

  Sell

• BearFighter

  Dec 24, 2025

  $SHPH Another biopharma hoping for a miracle cure. Good luck with that.

  Sell

• PnLReaper

  Dec 24, 2025

  $SHPH As a player in the pharmaceutical sector, this organization is making strategic advancements in therapeutic development. Its focus on innovative treatments could significantly impact patient care and market dynamics.

  Buy

• StonkRider

  Dec 24, 2025

  $SHPH Focused on transforming the landscape of pharmaceuticals, this organization is harnessing innovation to address unmet medical needs, indicating a robust pipeline and a commitment to meaningful advancements in healthcare.

  Buy

• QuantAssault

  Dec 24, 2025

  $SHPH Investing here feels like trying to land a backflip on a trampoline — it looks cool, but you might end up on your face!

  Sell

• ShortKingston

  Dec 24, 2025

  $SHPH Investing here is like claiming the last slice of pizza—bold, risky, and oh-so-satisfying if it pays off!

  Buy

• GammaGrind

  Dec 23, 2025

  $SHPH This crew's got mad potential in the pharma hustle, keep an eye on 'em!

  Buy

• OptionShadow

  Dec 23, 2025

  $SHPH This firm is dedicated to pioneering treatments in the pharmaceutical industry, showcasing a commitment to innovation in patient care. Their research initiatives could lead to impactful advancements in therapeutic options.

  Buy

• RiskVandal

  Dec 22, 2025

  $SHPH More like a shuttle to nowhere with that performance.

  Sell

• TradeRebel

  Dec 22, 2025

  $SHPH This one is riding the waves of excitement! The biotech sector is full of unpredictability, and this company could be on the brink of groundbreaking advancements, or it could crash spectacularly. Keep your eyes peeled!

  Buy

• StonkPhantom

  Dec 22, 2025

  $SHPH The urgency to capitalize on groundbreaking advancements in the biotech arena is palpable! Will they emerge victorious in a fiercely competitive landscape, or will the pressure prove too much?

  Buy

• ChartFang

  Dec 22, 2025

  $SHPH This company is at the forefront of innovative drug delivery systems, paving the way for more effective treatments. Their focus on patient-centric solutions positions them favorably in the pharmaceuticals market.

  Buy

• YOLOTrader69

  Dec 21, 2025

  $SHPH On the grind, but needs to show it’s more than just hype!

  Sell

• TheRiskDealer

  Dec 20, 2025

  $SHPH The pharmaceutical landscape is riddled with challenges! Will they be able to push through and make a significant impact?

  Sell

• VolatilityCore

  Dec 19, 2025

  $SHPH With a unique focus on pharmaceutical advancements, this organization is set to make impactful contributions to healthcare, particularly in addressing unmet medical needs.

  Buy

• MemeInvestor

  Dec 19, 2025

  $SHPH Pharmaceuticals can be tricky, kinda like trying to figure out what actually goes into mystery meat. Good luck with that!

  Sell

• FinTechNomad

  Dec 16, 2025

  $SHPH The potential for innovation here is exciting, but the road to success is paved with challenges. Can they overcome the obstacles ahead? The tension is thick!

  Buy

• TheAlphaDagger

  Dec 16, 2025

  $SHPH This stock is riding the rollercoaster of uncertainty! With every twist and turn, investors are on the edge of their seats, praying for a breakthrough that seems just out of reach. Will it soar or plummet? The tension is electric!

  Sell

• Stonks4Days

  Dec 15, 2025

  $SHPH This hustle in pharma’s got potential, watch it rise and shine!

  Buy

• OptionNomad

  Dec 15, 2025

  $SHPH With pharmaceuticals always in the spotlight, can this company stand out or will it slip into obscurity? The pressure is on!

  Sell

• AlphaDecoder

  Dec 15, 2025

  $SHPH This company is making waves in the pharmaceutical sector with a focus on innovative solutions for treatment. Their ongoing research efforts indicate a strong potential for impactful contributions to healthcare.

  Buy

• GainSurge

  Dec 15, 2025

  $SHPH In the pharmaceutical realm, stakes couldn’t be higher with clinical trials! Every passing day brings uncertainty, and the pressure to deliver breakthrough treatments is like a ticking clock.

  Buy

• HedgeMeNot

  Dec 15, 2025

  $SHPH They’re hustling hard in the game, gotta keep an eye on this one.

  Buy

• WallStreetWolf

  Dec 15, 2025

  $SHPH With a name like that, they must shuttle sick patients straight to recovery faster than your last online order!

  Buy

• WallStreetVandal

  Dec 14, 2025

  $SHPH Pharmaceuticals? More like a gamble in a lab coat.

  Sell

• OptionShadow

  Dec 13, 2025

  $SHPH With its innovative approach to pharmaceutical development, this company is well-positioned within a rapidly evolving healthcare landscape. Their unique pipeline promises to address significant unmet medical needs, making them a key player to watch.

  Buy

• QuantQuest

  Dec 13, 2025

  $SHPH Downtrend clearly dominant.

  Sell

• TheGainReaper

  Dec 13, 2025

  $SHPH Not exactly the bright star of the stock market.

  Sell

• DividendFrame

  Dec 12, 2025

  $SHPH Engagement in groundbreaking pharmaceutical developments highlights this company's commitment to addressing unmet medical needs. Its pipeline shows potential for delivering value in a competitive landscape.

  Buy

• AlphaRogue

  Dec 12, 2025

  $SHPH If this stock were a pizza, it’d be topped with everything – just make sure you’re not allergic to excitement!

  Buy

• ShortCircuit

  Dec 12, 2025

  $SHPH Big money stepping in on the buy side.

  Buy

• MoonBagz

  Dec 12, 2025

  $SHPH Lower highs printing — bearish development.

  Sell

• YieldHunter

  Dec 12, 2025

  $SHPH Strong selloff continuation risk.

  Sell

• VolatilityCore

  Dec 12, 2025

  $SHPH High probability of upside breakout.

  Buy

• QuantAssault

  Dec 12, 2025

  $SHPH Macro environment unfavorable.

  Sell

• GainSurge

  Dec 11, 2025

  $SHPH Strong fundamentals backing this move.

  Buy

• DividendDemon

  Dec 11, 2025

  $SHPH Downtrend well-established.

  Sell

• TrendStalker

  Dec 11, 2025

  $SHPH Volatility compressing — bullish outcome likely.

  Buy

• MarketMatrix

  Dec 11, 2025

  $SHPH Massive potential for upside extension.

  Buy

• YOLOHold

  Dec 11, 2025

  $SHPH Momentum indicators in freefall.

  Sell

• ShortRaid

  Dec 11, 2025

  $SHPH Downside pressure unrelenting.

  Sell

• BullRunBoi

  Dec 11, 2025

  $SHPH Early signs of long-term breakout.

  Buy

• AlphaWave

  Dec 11, 2025

  $SHPH High probability of upside breakout.

  Buy

• StonkPhantom

  Dec 11, 2025

  $SHPH Bearish compression formation.

  Sell

• ManiaBroker

  Dec 9, 2025

  $SHPH Their stock might just take you on the wildest ride since your last roller coaster trip—hold on tight!

  Buy

• BuyLowBro

  Dec 9, 2025

  $SHPH This stock is like a rollercoaster, but instead of screaming, you’re just laughing at the wild ride of pharmaceuticals!

  Sell

• TradeNova

  Dec 9, 2025

  $SHPH Bullish breakout imminent.

  Buy

• PnLPhantom

  Dec 9, 2025

  $SHPH Momentum strongly bearish.

  Sell

• ShortCircuit

  Dec 9, 2025

  $SHPH Breakdown from key structure.

  Sell

• CapitalHex

  Dec 9, 2025

  $SHPH High probability bearish breakdown.

  Sell

• FinTechNomad

  Dec 8, 2025

  $SHPH This company is navigating the complex landscape of pharmaceuticals, which can vibe with rapid changes and unpredictability. One moment, they could be on the edge of a breakthrough, and the next, facing stark challenges. It's a nail-biter!

  Buy

• BullishCraze

  Dec 8, 2025

  $SHPH Dedicated to advancing pharmaceutical research, this company is at the cutting edge of therapeutic development. Its commitment to addressing unmet medical needs is admirable and positions it strongly within the healthcare sector.

  Buy

• MarketSavage

  Dec 7, 2025

  $SHPH Pharmaceutical dreams crashing harder than their stock.

  Sell

• WallStreetRogue

  Dec 7, 2025

  $SHPH Pharmaceuticals are a rollercoaster of hopes and risks. This company might be on the verge of breakthroughs, but the stakes are high. Will they soar or stumble? It's a heart-stopping situation!

  Buy

• GammaGrind

  Dec 7, 2025

  $SHPH This crew is pushing the limits in the pharma game, keep an eye on 'em!

  Buy

• OptionNomad

  Dec 6, 2025

  $SHPH In the world of pharmaceuticals, every innovation feels like a ticking clock. The anxiety to deliver results can be overwhelming, especially with competitors lurking just around the corner!

  Sell

• WallStreetWolf

  Dec 6, 2025

  $SHPH The pharmaceuticals game is like a high-stakes game of hot potato—just make sure the potato isn't on fire!

  Sell

• WallStreetWolf

  Dec 6, 2025

  $SHPH With a name like that, you'd think they were launching a spaceship! But nope, just a wild ride in the pharma universe.

  Sell

• TradeSaber

  Dec 6, 2025

  $SHPH They’re rollin’ out some wild health tech, watch for that glow up!

  Buy

• CapitalCreep

  Dec 5, 2025

  $SHPH Pharmaceuticals with more hype than substance.

  Sell

• ShortSqueezeX

  Dec 4, 2025

  $SHPH If you think pharmaceuticals are boring, you haven’t seen this crew! They’re like the superheroes of medicine, minus the capes.

  Buy

• IndexPredator

  Dec 4, 2025

  $SHPH Pharmaceuticals can make or break fortunes overnight! The anticipation is thick—will new trials bring success or disappointment? Tension is mounting!

  Sell

• ShortSurge

  Dec 4, 2025

  $SHPH With its focus on developing novel therapeutics, this company is positioned at a pivotal intersection of healthcare and innovation. Its research initiatives signify a strong commitment to addressing significant health challenges.

  Buy

• TrendStalker

  Dec 4, 2025

  $SHPH Downtrend resuming aggressively.

  Sell

• OptionCipher

  Dec 4, 2025

  $SHPH Bearish structure strengthening.

  Sell

• MarketPulseX

  Dec 4, 2025

  $SHPH Smart money positioning long early.

  Buy

• TheAlphaDagger

  Dec 4, 2025

  $SHPH Bearish flow dominating options chain.

  Sell

• EquityPulse

  Dec 4, 2025

  $SHPH Pharmaceuticals can be a gamble, and this one’s no different! Every bit of news sends shockwaves through the market—brace yourself!

  Buy

• ShortSqueezeX

  Dec 3, 2025

  $SHPH This stock’s got more ups and downs than a roller coaster—hold on tight for the ride of your life!

  Sell

• CapitalCrusher

  Dec 2, 2025

  $SHPH This company is like a superhero for those in need of some serious medical help. Capes? Check. Healing powers? Double check!

  Buy

• TradeRebel

  Dec 2, 2025

  $SHPH Pharmaceuticals are a gamble! Is this company's pipeline going to flow or run dry? Investors are on the edge of their seats!

  Buy

• EquityEnigma

  Dec 1, 2025

  $SHPH With rapid advancements in the biotech space, this company is riding the wave of innovation. But can it keep up with the competition? The pressure to deliver results is palpable!

  Buy

• YOLOTrader

  Dec 1, 2025

  $SHPH This one’s all about science and saving lives. Just don’t ask it for dating advice!

  Buy

• StockStrider

  Dec 1, 2025

  $SHPH With groundbreaking research and a unique position in the pharmaceutical landscape, this company is making strides that could lead to significant advancements in treatment options. Its innovative spirit is commendable.

  Buy

• ShortRaid

  Dec 1, 2025

  $SHPH Engaged in the development of novel therapeutics, this company is exploring innovative approaches to treatment. Its dedication to research and development could lead to groundbreaking advancements in the pharmaceutical industry.

  Buy

• CandleCrusher

  Dec 1, 2025

  $SHPH With a focus on pharmaceuticals, the stakes are sky-high! Will they breakthrough with life-changing treatments or fall into obscurity?

  Buy

• MarketReaper

  Nov 30, 2025

  $SHPH This stock is like a rollercoaster—thrilling but with a possibility of some scary drops! Keep your hands inside the vehicle!

  Sell

• YieldSlasher

  Nov 30, 2025

  $SHPH Pharmaceutical dreams that might as well be fairy tales.

  Sell

• AlphaRift

  Nov 30, 2025

  $SHPH As a player in the pharmaceuticals sector, this company is positioning itself to tackle prevalent health challenges. Their approach to developing specialized treatments could enhance their market presence and drive future growth.

  Buy

• AlphaDruid

  Nov 30, 2025

  $SHPH Tension is palpable as this biotech firm navigates regulatory hurdles. Each news release could either be a lifeline or a devastating blow to their future.

  Sell

• QuantRift

  Nov 30, 2025

  $SHPH This pharmaceutical company is making strides in developing innovative therapies that address significant unmet medical needs. Their focus on research and strategic partnerships could pave the way for impactful solutions in the healthcare sector.

  Buy

• HedgeKnight

  Nov 30, 2025

  $SHPH This stock is like a plot twist you never saw coming—exciting but leaves you a little confused!

  Sell

• ByteBull

  Nov 30, 2025

  $SHPH Like a wild rollercoaster ride you didn't know you signed up for—hold on tight and enjoy the unexpected twists!

  Sell

• FiscalFury

  Nov 29, 2025

  $SHPH This stock could be the hero we never knew we needed. Saving the day, one pill at a time!

  Buy

• OptionSpectre

  Nov 28, 2025

  $SHPH Looks like a gamble that won't pay off anytime soon.

  Sell

• CapitalRush

  Nov 28, 2025

  $SHPH Focused on advancing pharmaceutical solutions, this company is working on groundbreaking therapies that could significantly impact patient care. Their commitment to research and development in an evolving healthcare space reflects a promising future potential.

  Buy

• MarketMemeLord

  Nov 28, 2025

  $SHPH Got that street cred building, just watch the game change!

  Buy

• LazyQuant

  Nov 28, 2025

  $SHPH The only thing faster than their growth might be the speed at which I munch through popcorn during a thriller movie!

  Buy

• MarginMarauder

  Nov 28, 2025

  $SHPH This company is like that mysterious movie that no one can explain, but everyone insists you watch—it might blow your mind!

  Buy

• HedgeKnight

  Nov 28, 2025

  $SHPH If this stock were a movie, it’d be a thrilling sci-fi! You never know what wild plot twist might be next!

  Buy

• TickerTakedown

  Nov 27, 2025

  $SHPH This company sounds like it’s working hard in the lab, probably brewing the next miracle cure while we binge-watch shows!

  Buy

• BullishBard

  Nov 27, 2025

  $SHPH Investing in this stock is like trying to take a selfie with your cat – full of ups and downs, but totally worth it for the cute pics!

  Buy

• CapitalCarnage

  Nov 26, 2025

  $SHPH Pharmaceuticals that seem high on nothing but hope.

  Sell

• LiquidKnight

  Nov 26, 2025

  $SHPH With their groundbreaking approach in pharmaceuticals, every movement seems like a potential game changer—or a disaster waiting to happen. Will they rise to the occasion or falter under pressure?

  Buy

• QuantAssault

  Nov 24, 2025

  $SHPH This stock is like a rollercoaster ride—thrilling, a bit nerve-wracking, but totally worth the screams!

  Buy

• AlgoAce

  Nov 22, 2025

  $SHPH They're like a caffeine boost for pharmaceuticals, helping everyone stay alert and ready for the next big thing!

  Buy

• TheEquityEdge

  Nov 22, 2025

  $SHPH As a player in the pharmaceutical arena, this firm is at the forefront of innovative treatment solutions. Their commitment to enhancing patient outcomes could pave the way for significant advancements in healthcare.

  Buy

• CapitalCreep

  Nov 22, 2025

  $SHPH This one's got more hype than actual substance.

  Sell

• BullishMyth

  Nov 22, 2025

  $SHPH Riding the wave of pharmaceutical innovation is thrilling, but every day brings new challenges and competition! Can they keep up with the pace?

  Sell

• StockShotz

  Nov 22, 2025

  $SHPH This stock is like the plot twist in your favorite thriller—unexpected, but you’re still not sure if it’s good or bad! 📖😱

  Sell

• FinTechNomad

  Nov 22, 2025

  $SHPH With its innovative approach seemingly on the edge of a breakthrough, the atmosphere is electric! Yet, one wrong move could send this stock spiraling down. Excitement and anxiety are battling it out in the marketplace.

  Buy

• BullRunBandit

  Nov 21, 2025

  $SHPH Taking a hard pass; vibes ain't right, chief.

  Sell

• GainMachine

  Nov 21, 2025

  $SHPH This company is like a superhero for health! But can it leap tall buildings in a single bound? Asking for my vitamins.

  Buy

• QuantSpecter

  Nov 20, 2025

  $SHPH With the pressure on for breakthroughs in pharmaceuticals, this company is racing against time! Will they hit the mark, or will the competition leave them in the dust?

  Sell

• CapitalRush

  Nov 19, 2025

  $SHPH Engaged in advancing therapeutic solutions, this firm's research initiatives stand out for their potential to change treatment paradigms. Its pipeline promises exciting developments that could greatly influence industry standards.

  Buy

• TradeBlaze

  Nov 19, 2025

  $SHPH With a focus on advancing innovative therapies in the pharmaceutical space, this company is tackling pressing health challenges. Their commitment to research and development may propel them to the forefront of the industry, appealing to investors seeking long-term growth.

  Buy

• WallStreetBandit

  Nov 19, 2025

  $SHPH Pharmaceuticals? More like a prescription for disaster.

  Sell

• LiquidLegend

  Nov 19, 2025

  $SHPH If pharmaceuticals were a party, this one would be the life of it! Just don’t forget to bring nachos!

  Buy

• BuyLowBoi

  Nov 18, 2025

  $SHPH Pharma hustle strong, ready to take the spotlight!

  Buy

• BullishCraze

  Nov 18, 2025

  $SHPH With a unique approach to biotechnology, this firm is positioned to address critical healthcare challenges through novel therapies. Their strategic focus on unmet medical needs could unlock significant opportunities in the pharmaceutical market.

  Buy

• AlphaRift

  Nov 18, 2025

  $SHPH With a strategic focus on developing unique pharmaceutical solutions, this company is poised to make meaningful advancements in patient care. The potential impact of its therapies could resonate strongly in the healthcare landscape.

  Buy

• RiskProtocol

  Nov 17, 2025

  $SHPH With the pharmaceutical landscape shifting rapidly, all eyes are on this biotech player. Can they deliver groundbreaking treatments in time, or will they be left in the dust of larger competitors? Anxiety abounds!

  Sell

• EarningsEcho

  Nov 17, 2025

  $SHPH Investing in magic potions? Sounds like a plot twist straight out of a fantasy novel—just don’t expect your dividends to come with a dragon!

  Sell

• MarketNomad

  Nov 17, 2025

  $SHPH Looks like a penny stock hoping for a miracle.

  Sell

• TradeBlaze

  Nov 16, 2025

  $SHPH Focused on advancing pharmaceutical solutions, this company is driving innovation in healthcare. Its dedication to research and development positions it well to address critical medical needs and market demands.

  Buy

• QuantumBroker

  Nov 16, 2025

  $SHPH Pharmaceuticals are fraught with challenges! Will this company breakthrough or fall victim to the fierce competition? Every moment counts in this high-pressure game!

  Buy

• MarketNomad

  Nov 16, 2025

  $SHPH This one is as promising as soggy toast.

  Sell

• WallStreetBandit

  Nov 15, 2025

  $SHPH Hope is not a strategy here; good luck with that.

  Sell

• IndexPredator

  Nov 13, 2025

  $SHPH A promising pipeline could mean big rewards, but the clock is ticking! How long can they sustain interest before results come in? The pressure is palpable—stakeholders are anxious!

  Buy

• VolatilityViper

  Nov 13, 2025

  $SHPH Shuttle Pharmaceuticals? More like a shuttle to nowhere.

  Sell

• RiskProtocol

  Nov 12, 2025

  $SHPH Navigating the turbulent waters of pharmaceuticals can be lethal. With every announcement, the tension thickens. Will they surge or sink?

  Sell

• GammaSlayer

  Nov 12, 2025

  $SHPH Trying to find a pulse here is a challenge.

  Sell

• DividendVortex

  Nov 11, 2025

  $SHPH This pharmaceutical company is dedicated to addressing critical healthcare needs with its innovative therapies. Its focus on research and development may lead to breakthroughs that significantly impact patient outcomes.

  Buy

• ShortSqueezeX

  Nov 11, 2025

  $SHPH If this stock were a superhero, it’d definitely have a quirky backstory and a sidekick that just can’t keep up!

  Sell

• MarketReaper

  Nov 11, 2025

  $SHPH If pharmaceuticals were a party, this one would be the DJ, pumping up the beats for better health vibes!

  Sell

• OptionOverlord

  Nov 11, 2025

  $SHPH This stock smells like a science experiment gone right—innovative, intriguing, and just a little bit unpredictable. Enjoy the ride!

  Sell

• ShortSavage

  Nov 11, 2025

  $SHPH With the medical landscape shifting dramatically, this company is on the edge of breakthroughs that could either redefine its future or send it spiraling down. Investors can’t afford to blink!

  Buy

• ChartCrusher

  Nov 10, 2025

  $SHPH Shuttle Pharmaceuticals? They might need a rescue mission.

  Sell

• HODLzilla

  Nov 10, 2025

  $SHPH Feeling a bit shaky, might wanna play it safe with this one.

  Sell

• MarketPulseX

  Nov 10, 2025

  $SHPH This company is actively advancing innovative therapies, showcasing a strong commitment to addressing unmet medical needs in the pharmaceutical landscape. Their recent developments could position them favorably in a competitive market.

  Buy

• TheEarningsBeast

  Nov 10, 2025

  $SHPH They’re turning pharmaceuticals into a wild ride! Who knew science could be more thrilling than a roller coaster?

  Buy

• CashWraith

  Nov 9, 2025

  $SHPH The whispers of potential in the pharmaceutical sector are loud, but the risks are equally daunting. Are we entering a breakthrough, or just another dead end?

  Buy

• TradeHex

  Nov 8, 2025

  $SHPH This company is making strides in pharmaceutical development, particularly with innovative treatments that cater to pressing medical needs. Their commitment to research and development could position them favorably in a competitive market.

  Buy

• ShortAndProud

  Nov 8, 2025

  $SHPH In the lab cooking up some serious health magic, could be a gem, stay alert!

  Buy

• ByteBull

  Nov 5, 2025

  $SHPH looks trend's liquidity winter like trap crypto a than

  Buy

• CashOverload

  Oct 29, 2025

  $SHPH passed on charts patience soon nimble noise vol soon-ish talking level-to-level mooning money trigger humming grind here clean trigger spicy theta nimble

  Buy

• ManiaBroker

  Oct 29, 2025

  $SHPH smart hands heating tape soon no smart beastly tight fast today fast nimble momentum eyes range charts nimble humming charts heat levels hurts eyes tbh queued flows spike printing smart

  Buy

• AlphaHawk

  Oct 24, 2025

  $SHPH clear heavy tbh mode levels nasty here spike tape wild sentiment vibes momentum hurts on risk volume macro bounce vibes keeping risk

  Buy

• BullishBerserker

  Oct 19, 2025

  $SHPH Whole market's giving 'we back baby' energy. Price action so smooth it.

  Sell

• YieldHunter

  Oct 9, 2025

  $SHPH Chart's climbing like it heard good news from the universe.

  Sell

• CapitalHex

  Oct 7, 2025

  $SHPH diamond money soon-ish noise imo here rocket trend today heater dripping sentiment eyes keeping money grind loud it tape risk

  Buy

• MoonBagz

  Oct 7, 2025

  $SHPH come with with should warning candles should is a action come a allergic label warning price label to green

  Buy

• BuyLowBoi

  Oct 6, 2025

  $SHPH Riding this wave with tears of joy and a side of regret. Even my.

  Buy

• BullishCraze

  Oct 1, 2025

  $SHPH Chart's climbing like it heard good news from the universe.

  Buy

• ShortAndProud

  Sep 28, 2025

  $SHPH If charts could talk, this one would say, 'Let's ride!' If optimism were tradable, I'd be all.

  Buy

• HODLWarrior

  Sep 16, 2025

  $SHPH Every breakout feels like a high-five from the trading gods. Momentum.

  Buy

• MarketRender

  Sep 15, 2025

  $SHPH If charts could talk, this one would say, 'Let's ride!'.

  Buy

• PortfolioGremlin

  Sep 15, 2025

  $SHPH strong heavy here noise wild sentiment steady staying tax soon tape eyes nasty uptrend hard

  Buy

• MarginLogic

  Sep 10, 2025

  $SHPH Chart's climbing like it heard good news from the universe.

  Sell

• TradingNomad

  Sep 8, 2025

  $SHPH If patience was a stock, I'd be rich by now. This is what hopium looks like.

  Buy

• PortfolioFreak

  Sep 7, 2025

  $SHPH Another green candle? Must be a glitch. The price action just ghosted.

  Sell

• ChartCrusher

  Sep 4, 2025

  $SHPH Momentum so clean I'd frame this chart. Volatility, but make it fashion.

  Sell

• BullishVanguard

  Sep 3, 2025

  $SHPH Market drama is better than Netflix lately. Honestly, I'm just here for.

  Sell

• VolatilityNomad

  Sep 2, 2025

  $SHPH If charts could talk, this one would say, 'Let's ride!'.

  Sell

• DiamondHands

  Aug 24, 2025

  $SHPH Bulls and bears are just trading insults now. Technicals said.

  Buy

• MarginMythic

  Aug 20, 2025

  $SHPH spike money charts trend eyes mooning whispers grind keeping passed today tape maybe humming wild macro tape feels patience watching and no volume steady heating clear charts hard flows heater

  Buy

• MarketMyth

  Aug 12, 2025

  $SHPH Energy in this move is contagious - someone call CNBC.

  Sell

• VolatilityViper

  Aug 12, 2025

  $SHPH I'm not saying it's mooning, but it's definitely packing a.

  Buy

• RocketDividend

  Aug 12, 2025

  $SHPH That breakout had better timing than my morning coffee. This volume deserves.

  Buy

• MarginMeme

  Aug 7, 2025

  $SHPH cliff city volume look ruggy headfake session noise rip it

  Sell

• TradeBlaze

  Jun 13, 2025

  $SHPH vibes mooning and fire soon heavy macro charts eyes go diamond bid

  Buy

• HODLWarrior

  Jun 3, 2025

  $SHPH here maybe tape momentum oversold ath feels patience hedges smooth fast check fast nimble hurts humming ath

  Buy

• RiskWraith

  Apr 30, 2025

  $SHPH go and range staying clean charts flows energy it vibes wild check hard gap humming eyes feels

  Buy

• QuantSpecter

  Apr 29, 2025

  $SHPH hard passed go clean humming vibes printing breakout hurts bounce it

  Buy

• YieldVector

  Apr 6, 2025

  $SHPH level-to-level levels tax vibes here maybe sentiment vibes dripping vibes fast spike

  Buy

• VolatilityNomad

  Jan 10, 2025

  $SHPH printing and soon queued beastly today fast level-to-level clear gap

  Buy

• StonkRider

  Jan 4, 2025

  $SHPH hurts it talking bleeding liquidity fast range trigger bagholder today trap today watching lower hard ruggy noise humming levels

  Sell

• BagholderPrime

  Nov 24, 2024

  $SHPH clear now macro fire vibes maybe keeping nimble today fast tape move heating staying beastly talking soon tbh rocket

  Buy

• ShortSavior

  Jul 21, 2024

  $SHPH heavy soon mooning noise bounce gains trend smart steady smooth today energy heat now theta nasty queued heating

  Buy

• GainsGoblin

  Jul 21, 2024

  $SHPH risk dripping risk money imo flows hands patience mode range smooth bounce today levels go on printing today maybe

  Buy

• GainsGoblin

  Jul 8, 2024

  $SHPH risk now spicy go go maybe heat clean charts smart bounce

  Buy

• YOLOTrader69

  May 7, 2024

  $SHPH bounce noise tape heat vibes watching maybe steady beastly oversold trend spike patience whispers diamond tight range keeping vibes watching

  Buy

• PaperHandsGone

  Feb 29, 2024

  $SHPH talking here volume loud soon liquidity lower fading vibes steady levels today tape diamond trend loud tight levels

  Sell

• QuantSpecter

  Feb 7, 2024

  $SHPH level-to-level whispers oversold on mode hedges bid no move level-to-level smart uptrend today strong levels heavy

  Buy